CCNB1 and glioblastoma: It has been demonstrated that GA treatment reduced the Cdc2-HSP90 and Cdc2-cyclin B1 complexes in a GBM cell line, inducing the ubiquitination and proteasomal degradation of Cdc2 and cyclin B1, ultimately leading to G2/M cell cycle arrest and reduced cell proliferation [31].